[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
May 24/31, 2000

A Critical Pathway for Treatment of Community-Acquired Pneumonia—Reply

Author Affiliations

Phil B.FontanarosaMD, Deputy EditorIndividualAuthorStephen J.LurieMD, PhD, Contributing EditorIndividualAuthor

JAMA. 2000;283(20):2654-2655. doi:10.1001/jama.283.20.2653

In Reply: We acknowledge that the average LOS is shorter in the United States than in Canada. Differences also may exist in quality of care, patient satisfaction, and outcomes. However, the optimum LOS for community-acquired pneumonia has not been established. The statement of Drs Burgess and Lewis that "patients are discharged approximately 1 day after conversion to oral therapy" in the United States is based on a single-center, uncontrolled, descriptive study.1 Importantly, quality of life was not evaluated. Therefore, whether this policy is consistent with good patient care or is common throughout the United States is unknown.